Skip to main content
Clinical Trials/NCT01891903
NCT01891903UnknownNot Applicable

TO TRANSLATE AND VALIDATE THE ToPAS (TORONTO PSORIATIC SCREENING QUESTIONNAIRE) FOR THE SCREENING OF PSORIATHIC ARTHRITIS PATIENTS IN DERMATOLOGY CLINICS

Reumatologia Integral LTDA1 site in 1 country60 target enrollmentStarted: May 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
The Kuder Richardson Coefficient of reliability (K-R 20)

Study Overview

Brief Summary

TO TRANSALETE AND VALIDATE DE TORONTO PSORIATIC ARTHRITIS SECREENING QUESTIONAIRE INTO SPANISH

Detailed Description

THIS IS PART OF THE COLOMBIAN REGISTRY OF PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS

Study Design

Study Type
Observational
Time Perspective
Prospective

Eligibility Criteria

Ages
16 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • ADULT WITH PSORIASIS IN THE DERMATOLOGY CLINIC

Exclusion Criteria

  • ADULT WITH OTHER AUTOIMMUNE DISEASE

Outcomes

Primary Outcomes

The Kuder Richardson Coefficient of reliability (K-R 20)

Time Frame: 4 MONTHS

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Reumatologia Integral LTDA
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Adriana Beltran

ADRIANA BELTRAN OSTOS

Reumatologia Integral LTDA

Study Sites (1)

Loading locations...

Similar Trials

to Translate and Validate the TOPAS... | Clinical Trial